Seveso, Italy

Sergio Riva

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2001-2010

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Sergio Riva

Introduction

Sergio Riva is a prominent inventor based in Seveso, Italy, known for his significant contributions to the field of chemical synthesis. With three patents to his name, Riva has made notable advancements, particularly in pharmaceutical intermediates.

Latest Patents

Among his latest patents is the innovative process for the synthesis of intermediates for the preparation of pramipexol. This process involves the preparation of an acid that serves as either the (R) or (S) enantiomer, utilizing a lipase to achieve a mixture which is then hydrolyzed. Riva’s meticulous approach results in a high degree of stereochemical control. Another important patent of his is an enzymatic process for the preparation of intermediates that are essential in the synthesis of (−) modafinil, showcasing his expertise in the realm of complex organic compounds.

Career Highlights

Sergio Riva has had a successful career in the pharmaceutical industry, working with esteemed companies such as Dipharma S.p.A. and Dipharma Francis S.r.l. His work has significantly contributed to advancements in drug development and manufacturing processes.

Collaborations

Throughout his career, Riva has collaborated with various notable individuals in the field. Notably, he has worked alongside Paola Fassi and Pietro Allegrini, contributing to a dynamic exchange of ideas and innovations which have further propelled his inventions.

Conclusion

Sergio Riva exemplifies the spirit of innovation in the pharmaceutical sector. His dedication to developing efficient synthesis processes has not only led to multiple patents but has also aided in the progress of medicinal chemistry. As the field continues to evolve, inventors like Riva will remain at the forefront, driving advancements that benefit both science and society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…